Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Ejhaem|February 26, 2024
Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factorsB Linder Grønvold, Maryan Mohamed Ali, Tor Å Myklebust, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2012
Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host diseaseOlle Ringdén, Mats Remberger, Katarina Holmberg, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 15, 2023
Allogeneic stem cell transplantation in adults 2015-21Camilla Dao Vo, Anders Eivind Myhre, Ingerid Weum Abrahamsen, et al.
European Journal of Haematology|October 4, 2021
Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell graftsIgor Novitzky-Basso, Mats Remberger, Carol Chen, et al.
Clinical Transplantation|September 12, 2007
Hemorrhagic cystitis: a retrospective single-center surveyZuzana Hassan, Mats Remberger, Petter Svenberg, et al.
Frontiers in Immunology|July 5, 2017
Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host DiseaseArwen Stikvoort, Yang Chen, Emelie Rådestad, et al.
Transplantation|May 30, 2006
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host diseaseOlle Ringdén, Mehmet Uzunel, Ida Rasmusson, et al.
Transplantation and Cellular Therapy|June 13, 2025
Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant with Graft Failure and Relapse Risk in Hematological MalignanciesAhmed Alnughmush, Mats Remberger, Vathany Kulasingam, et al.
Pageof 18